Radboud University Medical Center
Just Landed
2 days ago
PhD in Modulating the Tumor Microenvironment to Enhance Radiosensitivity Radboud University Medical Center in Netherlands
Degree Level
PhD
Field of study
Immunology
Funding
Fixed-term PhD contract for 4 years. Salary indicated at €3217–€4077 per month, plus 8% holiday allowance, 8.3% end-of-year bonus, travel allowance, public transport reimbursement, and home-working allowance.
Deadline
Oct 4, 2026
Country
Netherlands
University
Radboud University Medical Center

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
Apply for this position
Keywords
Suggested positions
About this position
Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands is recruiting a PhD candidate for a project titled “Modulating the tumor microenvironment to enhance radiosensitivity.”
This PhD position sits in the Radiotherapy & OncoImmunology (ROI) lab within the Department of Radiation Oncology. The project focuses on how the tumor microenvironment (TME) influences response to radiotherapy, with particular attention to stromal composition, hypoxia, cellular senescence, cancer-associated fibroblasts (CAFs), immune cells, and treatment resistance.
The research combines patient-derived models and in vivo tumor models with complementary preclinical approaches such as hypoxia modulation, targeting senescent cells or CAFs, image-guided radiotherapy, and immune checkpoint inhibition. You will assess treatment response and mechanisms using readouts including DNA damage and repair, tumor growth, and characterization of the TME.
Applicants should have an MSc degree in Biomedical Sciences, Biology, Cancer Biology, or a related field (or equivalent). A strong interest in preclinical cancer research is essential. Experience in molecular and cellular biology, tumor biology, radiobiology, or immunology is an advantage; experience with preclinical animal models is welcome. Candidates with an Article 9 certificate for experimental animals are especially encouraged.
The position is a fixed-term PhD contract for 4 years. The vacancy lists a salary indication of €3217–€4077 per month, plus holiday allowance, end-of-year bonus, travel reimbursement, public transport reimbursement, and home-working allowance.
Deadline: 4 October 2026. Location: Nijmegen, Netherlands.
To apply, use the AcademicTransfer application page. For questions, contact Marleen Ansems at Radboudumc.
Funding details
Fixed-term PhD contract for 4 years. Salary indicated at €3217–€4077 per month, plus 8% holiday allowance, 8.3% end-of-year bonus, travel allowance, public transport reimbursement, and home-working allowance.
What's required
MSc degree in Biomedical Sciences, Biology, Cancer Biology, or a related field, or an equivalent degree. Strong interest in preclinical cancer research and motivation to investigate biological mechanisms underlying treatment response. Curiosity, enthusiasm for experimental science, and ability to work in an interdisciplinary research environment are expected. Experience with molecular and cellular biology, tumor biology, radiobiology, or immunology is an advantage. Experience with preclinical animal models is welcome, and candidates with an Article 9 certificate for working with experimental animals are especially encouraged to apply.
How to apply
Apply via the AcademicTransfer vacancy page using the Apply now button. For more information, contact Marleen Ansems by email.
More information can be found here
Ask ApplyKite AI

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.